Gaucher disease research

Gaucher disease research

Give online
to Gaucher disease research

  • Phillippe Charles Ernest Gaucher
    Phillippe Charles Ernest Gaucher, discoverer of the disease

Professor Timothy Cox's research group is working to develop gene therapy for adults and children affected by the lysosomal disorder Gaucher disease.

Gaucher disease is one of the more common of the lysosomal disorders; it quite commonly affects adults as well as children.  The adult form usually starts in childhood and causes enlargement of the liver and spleen, painful conditions in the bone, anaemia, and a tendency to bleed.  In very young children it can also affect the brain, starting off with a simple squint, but sometimes progressing to a horrible form of epilepsy in adolescence or later childhood.  Nobody knows why this occurs, but gene therapy seems to offer some prospect for improvement, as does enzyme therapy delivered to the brain. Research into the disease and the brain condition associated with it would be well used by the research team.

Find out more

Gaucher disease research website

Gift announcements

Cambridge owes its world-leading excellence in research and teaching to the generosity of its supporters. Our history is synonymous with a history of far-sighted benefaction, and the same is as true today as it has ever been.

Gift announcement
Multi-million pound legacy to create a new 'Ray and Dagmar Dolby Court' at Pembroke College
Gift announcement
The University of Cambridge is launching a new research centre, thanks to a £10 million grant from the Leverhulme Trust, to explore the opportunities and challenges to humanity from the development of artificial intelligence. 

Impact of giving

Philanthropic giving is at the heart of the success of the Collegiate University, enabling us to make discoveries that change the world and to ensure that our students received an unrivalled education.

Wolfson Laser Lab
Philanthropic impact story
In 2016 the Department of Chemical Engineering and Biotechnology will bid farewell to central Cambridge and move into its new £60m purpose-built home on the West Cambridge Science and Technology Campus.
The new Laboratory of Molecular Biology at Addenbrooke's hospital
Philanthropic impact story
At any one time, more than 1000 clinical trials are being conducted across the Cambridge Biomedical Campus, the largest gathering of clinical, pharmaceutical and biomedical research specialists in Europe. These trials are a crucial step in the design of new medicines and medical devices – translating ideas that started in a research laboratory into new treatments for patients.